LAKE FOREST, Calif., April 24, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction ...

In this article, we are going to take a look at where STAAR Surgical Company (NASDAQ:STAA) stands against other stocks that insiders bought in April after Trump’s tariff rollout. President ...

Implantable lenses company STAAR Surgical (NASDAQ:STAA) said in a filing that its 10% owner Broadwood Partners has added shares worth $2.41M. Broadwood Partners bought 102,400 shares of common ...

Fintel reports that on April 21, 2025, Wells Fargo initiated coverage of STAAR Surgical (NasdaqGM:STAA) with a Equal-Weight recommendation. As of April 2, 2025, the average one-year price target ...

Analysts at Wells Fargo & Company assumed coverage on shares of STAAR Surgical (NASDAQ:STAA – Get Free Report) in a research note issued to investors on Monday, MarketBeat Ratings reports.

Staar Surgical issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods. The most recent guidance for Staar Surgical (STAA ...